VYNE Therapeutics Inc. (VYNE) Stock Analysis
DELISTED 2026
What happened to VYNE Therapeutics Inc. (VYNE) stock?
VYNE Therapeutics Inc. (VYNE) no longer trades on public markets. It was delisted in July 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2026
- Last recorded price (historical):
- $28.56 (last quote on record before the July 2026 delisting; historical, not a current quote)
Market cap $19.1M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
VYNE Therapeutics Inc. (VYNE). VYNE Therapeutics Inc. is a pharmaceutical company focused on developing therapies for immuno-inflammatory conditions, with pipeline assets including FCD105 for acne, FMX114 for atopic dermatitis, and VYN201/VYN202 as BET inhibitors.
Last analyzed: Jun 15, 2026VYNE Therapeutics Inc. (VYNE) Healthcare & Pipeline Overview
More about this archive record
Can I still buy VYNE shares?
No. VYNE stopped trading on public markets in July 2026, so the shares are not available through a broker. Anything you see quoted for VYNE elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VYNE stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to VYNE Therapeutics Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.